John Lorbiecki was appointed the Chief Operating Officer of Colorado Therapeutics in March of 2017. As the COO, he will be responsible for managing operations and oversight of manufacturing, regulatory, quality systems, and marketing of the Colorado Therapeutics product lines. During his 25-year career at Medtronic, Mr. Lorbiecki held several positions of increasing responsibility, most recently as Senior Finance Director of Strategic Scientific Operations where he was responsible for developing long-term and annual operating goals, providing business support to clinical, regulatory, reimbursement, and other strategic scientific operations in the company. Prior to that role, Mr. Lorbiecki held two divisional CFO roles, managed financial integration of multiple acquisitions, and provided analytical and strategic insight on high-value business development opportunities. During his term, he dedicated six years to managing the development of pricing strategy and tactics for the Cardiac Surgery division, including national accounts. He earned a MBA from the University of Chicago and a BA in Economics from the University of St. Thomas in St. Paul, Minnesota.